{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T14:11:24Z","timestamp":1696428684593},"reference-count":6,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We performed a retrospective case analysis to identify opportunities to introduce a patient-initiated follow-up (PIFU) pathway for patients with psoriasis completing narrowband ultraviolet B phototherapy at our centre. In total, 42 patients completed phototherapy between January 2016 and August 2018 and outcomes were observed for 36\u2005months after phototherapy cessation. Had a PIFU pathway been in place, 24 routine follow-up appointments could have been saved and 8 nonattendances could have been avoided. Seven patients who were discharged or did not attend follow-up after phototherapy flared within 12\u2005months and could have benefited from PIFU to re-access dermatology care. In total 21 patients (50.0%) experienced a relapse within 36\u2005months of completion of phototherapy, and 18 of these (85.7%) relapsed at 0\u201312\u2005months. The median time to relapse was 6\u2005months. We conclude a post-phototherapy PIFU pathway could help eliminate unnecessary appointments for patients in remission and improve access for patients who relapse. A 12-month PIFU duration prior to discharge would be sufficient to capture the majority of relapses.<\/jats:p>","DOI":"10.1093\/ced\/llac114","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T04:20:58Z","timestamp":1673497258000},"page":"368-370","source":"Crossref","is-referenced-by-count":0,"title":["Opportunities for implementing a patient-initiated follow-up pathway for patients with psoriasis completing phototherapy"],"prefix":"10.1093","volume":"48","author":[{"given":"Alpa","family":"Kanji","sequence":"first","affiliation":[{"name":"Department of Dermatology, Imperial College Healthcare NHS Trust , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khawar","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Imperial College Healthcare NHS Trust , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil P","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Imperial College Healthcare NHS Trust , London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,7]]},"reference":[{"key":"2023100315294660000_llac114-B1","author":"NHS England"},{"key":"2023100315294660000_llac114-B2","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/ced.14823","article-title":"Personal health records as a tool to support patient-initiated follow-up: a dermatology perspective","volume":"46","author":"Hussain","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"2023100315294660000_llac114-B3","author":"British Association of Dermatologists"},{"key":"2023100315294660000_llac114-B4","first-page":"301","article-title":"A prospective 52-week randomized controlled trial of patient-initiated care consultations for patients with psoriasis","volume":"179","author":"Khoury","year":"2018","journal-title":"Br J Dermatol"},{"key":"2023100315294660000_llac114-B5","author":"British Association of Dermatologists"},{"key":"2023100315294660000_llac114-B6","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1111\/jdv.17519","article-title":"The use of psoriasis biomarkers, including trajectory of clinical response, to predict clearance and remission duration to UVB phototherapy","volume":"35","author":"Watson","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llac114\/48623589\/llac114.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/4\/368\/51836472\/llac114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/4\/368\/51836472\/llac114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T17:15:47Z","timestamp":1696353347000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/4\/368\/6880766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,7]]},"references-count":6,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,12,7]]},"published-print":{"date-parts":[[2023,3,22]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llac114","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4]]},"published":{"date-parts":[[2022,12,7]]}}}